David Rosi

431 total citations
13 papers, 320 citations indexed

About

David Rosi is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, David Rosi has authored 13 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in David Rosi's work include Cancer Treatment and Pharmacology (3 papers), Synthesis and biological activity (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). David Rosi is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Synthesis and biological activity (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). David Rosi collaborates with scholars based in United States and Spain. David Rosi's co-authors include Sydney Archer, D. A. Berberian, H. Freele, Virendra Kumar, Malcolm R. Bell, John L. Herrmann, Thomas E. D'Ambra, Michael A. Eissenstat, E. W. Dennis and George P. Peruzzotti and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

David Rosi

12 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Rosi United States 7 123 77 66 66 63 13 320
Alfons H. M. Raeymaekers Belgium 9 45 0.4× 135 1.8× 26 0.4× 27 0.4× 159 2.5× 10 553
Mahmoud Abdel‐Latif Egypt 11 51 0.4× 100 1.3× 54 0.8× 45 0.7× 98 1.6× 30 382
Akira Koshiro Japan 11 28 0.2× 76 1.0× 33 0.5× 41 0.6× 94 1.5× 54 328
M. W. Goldberg United States 9 63 0.5× 109 1.4× 11 0.2× 19 0.3× 127 2.0× 21 310
Antonio Romo‐Mancillas Mexico 12 26 0.2× 131 1.7× 57 0.9× 50 0.8× 62 1.0× 31 419
C. H. Cashin United Kingdom 10 142 1.2× 86 1.1× 36 0.5× 3 0.0× 93 1.5× 25 398
Amy J. Campbell United States 10 105 0.9× 109 1.4× 12 0.2× 11 0.2× 43 0.7× 15 378
Kalpana Bhandari India 12 23 0.2× 113 1.5× 29 0.4× 24 0.4× 304 4.8× 31 480
M. H. Silk South Africa 10 14 0.1× 101 1.3× 13 0.2× 64 1.0× 34 0.5× 22 331

Countries citing papers authored by David Rosi

Since Specialization
Citations

This map shows the geographic impact of David Rosi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rosi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rosi more than expected).

Fields of papers citing papers by David Rosi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rosi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rosi. The network helps show where David Rosi may publish in the future.

Co-authorship network of co-authors of David Rosi

This figure shows the co-authorship network connecting the top 25 collaborators of David Rosi. A scholar is included among the top collaborators of David Rosi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rosi. David Rosi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wentland, Mark P., J. Andrew Carlson, Peter H. Dorff, et al.. (1995). Cyclic Variations of 3-Quinolinecarboxamides and Effects on Antiherpetic Activity. Journal of Medicinal Chemistry. 38(14). 2541–2545. 4 indexed citations
2.
Lockwood, G., et al.. (1995). A column-switching high-performance liquid chromatographic assay for a novel cytotoxic thioxanthone derivative (WIN 33377) in mouse plasma with toxicokinetic results from a mouse LD10 study. Journal of Chromatography B Biomedical Sciences and Applications. 670(1). 145–151. 6 indexed citations
3.
Bell, Malcolm R., Thomas E. D'Ambra, Virendra Kumar, et al.. (1991). Antinociceptive (aminoalkyl)indoles. Journal of Medicinal Chemistry. 34(3). 1099–1110. 123 indexed citations
4.
5.
Rosi, David, et al.. (1986). Comportamiento de los suelos para la confección de adobes. Informes de la Construcción. 37(377). 43–49. 3 indexed citations
6.
Rosi, David, et al.. (1981). Mutants of Streptomyces cattleya producing N-acetyl and deshydroxy carbapenems related to thienamycin.. The Journal of Antibiotics. 34(3). 341–343. 13 indexed citations
7.
Archer, Sydney, et al.. (1973). Synthesis of hycanthone. The Journal of Organic Chemistry. 38(9). 1743–1746. 14 indexed citations
8.
Bailey, Denis M., et al.. (1970). Synthesis and schistosomicidal activity of 6-chloro-5-[[2-(diethylamino)ethyl]amino]-8-quinolinemethanol. Journal of Medicinal Chemistry. 13(4). 598–601. 7 indexed citations
9.
10.
Berberian, D. A., et al.. (1967). Schistosomicidal Activity of Lucanthone Hydrochloride, Hycanthone and Their Metabolites in Mice and Hamsters. Journal of Parasitology. 53(2). 306–306. 31 indexed citations
11.
Berberian, D. A., et al.. (1967). Schistosomicidal activity of lucanthone hydrochloride, hycanthone and their metabolites in mice and hamsters.. PubMed. 53(2). 306–11. 35 indexed citations
12.
Rosi, David, et al.. (1967). Metabolism of 2,2-dichloro-N-[β-hydroxy-α- (hydroxymethyl)--(methylsulfinyl)- phenethyl]acetamide. Life Sciences. 6(13). 1351–1354. 2 indexed citations
13.
Rosi, David, George P. Peruzzotti, E. W. Dennis, et al.. (1965). A New, Active Metabolite of ‘Miracil D’. Nature. 208(5014). 1005–1006. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfons H. M. Raeymaekers Breakdown of academic impact, for papers by Mahmoud Abdel‐Latif Breakdown of academic impact, for papers by Akira Koshiro Breakdown of academic impact, for papers by M. W. Goldberg Breakdown of academic impact, for papers by Antonio Romo‐Mancillas Breakdown of academic impact, for papers by C. H. Cashin Breakdown of academic impact, for papers by Amy J. Campbell Breakdown of academic impact, for papers by Kalpana Bhandari Breakdown of academic impact, for papers by M. H. Silk
Rankless by CCL
2026